Medical Dissertation Reporting Guidelines: Matching CONSORT, STROBE, PRISMA and SQUIRE to Your Thesis Chapters

A medical dissertation is judged twice: once on what you found, and once on whether an examiner can check how you found it. The second judgement is where most clinical theses lose time. Reporting guidelines such as CONSORT, STROBE, PRISMA, STARD and SQUIRE exist to make that check fast, and committees increasingly expect a completed checklist with the final draft.

The problem is that each guideline was written for a single journal article, not a thesis that runs to several chapters and a few hundred pages. Candidates know which checklist applies but not where each item should live across five or six chapters. This guide fixes that: a design to guideline decision table, a chapter by chapter map of where checklist items land, the gaps committees flag most often, and how a DNP project differs from an MD, PhD, DrPH or PharmD thesis.

Why Reporting Guidelines Matter in a Medical Dissertation

Reporting guidelines are not quality scores. They do not say whether your study was good; they say whether a reader has enough information to decide. That distinction matters in a viva or defense, because examiners rarely object to a small sample or a modest effect. They object when they cannot tell how the sample size was chosen, how missing data were handled, or how many participants were lost between enrolment and analysis.

The EQUATOR Network maintains the library of these guidelines and their extensions. For a medical dissertation, four practical reasons make them worth adopting from the proposal stage, not the week before submission:

• They pre-empt committee questions. Each checklist item is, in effect, a question an examiner might ask. Answering it in the text removes it from the defense.
• They shorten the route to publication. Most clinical journals ask for the same checklist at submission, so a thesis chapter written to CONSORT or STROBE converts into a manuscript with far less rework.
• They structure the Methods chapter. The checklist order (setting, participants, variables, data sources, bias, study size, statistical methods) is a ready-made outline.
• They make supervision faster. A supervisor can review a chapter against 22 or 30 named items instead of reading for gaps by instinct.

Candidates in our medical dissertation support work often arrive with sound data and a well-argued Discussion, but with a Methods chapter that leaves examiners guessing. The fix is rarely more analysis. It is usually reporting what was already done, in the place a reader expects to find it.

Medical Dissertation Design to Guideline Decision Table

Start with your design, not your topic. A thesis on diabetes could be a trial, a cohort, a diagnostic accuracy study or a qualitative study, and each needs a different checklist. The table below covers the designs we see most often in clinical doctoral work. Where a design mixes components (for example, a trial with an embedded qualitative study), use the primary checklist for the main study and the second checklist for the embedded component.

Three version notes that catch candidates out

• CONSORT 2025 replaced CONSORT 2010. The 2025 update added seven items, revised three, deleted one and introduced a new open science section, giving a 30-item checklist plus the flow diagram.¹ If your trial was designed and approved under CONSORT 2010 (25 items) and your graduate school template still cites it, ask your committee which version they expect, then state the version in your Methods chapter.²
• SPIRIT 2025 is the protocol twin of CONSORT 2025. It has 34 items and adds a new item on patient and public involvement in trial design, conduct and reporting.¹⁰ Use it for a trial proposal or prospectus, then switch to CONSORT for the results thesis.
• PRISMA 2020 replaced PRISMA 2009. The 2020 statement has 27 items and a revised flow diagram that separates database records from records found by other methods.⁴ A thesis that still uses the 2009 diagram is an easy correction for an examiner to request.

If you are unsure which checklist fits a hybrid design, the Editverse decision tree for choosing a reporting guideline walks through edge cases such as pilot trials, prediction models and registry studies.

Where Checklist Items Land in Your Medical Dissertation Chapters

Journal checklists assume one manuscript with Introduction, Methods, Results and Discussion. A medical dissertation spreads the same content over more chapters, often with a separate literature review and sometimes with a published-papers format. The map below shows where each group of items belongs so that nothing is reported twice or not at all.

Methods carries most of the load

In every checklist we map, the Methods chapter carries the majority of items. That is why committees read it first and why a thin Methods chapter generates most revision requests. Write it in checklist order, using the guideline’s own sub-headings where your university template allows. STROBE, for example, runs setting, participants, variables, data sources and measurement, bias, study size, quantitative variables and statistical methods.³ Using that sequence as your sub-headings makes the checklist appendix almost self-completing.

Results is where the diagram goes

The participant flow diagram (CONSORT, STROBE, STARD) or the study selection diagram (PRISMA) should open the Results chapter, not sit in an appendix. It is the first thing an examiner checks against the stated sample size. The completed checklist goes in the appendix; the diagram stays in the body. If you need to draw one, the walkthrough in our PRISMA flow chart guide applies to the other flow diagrams too.

Published-papers theses need a bridge

In a thesis by publication, each paper already follows its own checklist. Committees still expect the linking chapters to explain how the papers connect, and some ask for each paper’s checklist in the appendix. Keep a single table that lists each paper, its design, its guideline and where its checklist sits.

Common Committee-Level Gaps in a Medical Dissertation

These are the reporting gaps that most often turn into revision requests at proposal review, pre-defense reading and final examination. Each one maps to a specific checklist item, which means each one is avoidable.

1. No flow diagram, or one that does not add up

The numbers in the diagram must reconcile at every step: assessed for eligibility, excluded with reasons, allocated or enrolled, lost to follow-up, analysed. If 412 were enrolled and 388 analysed, the 24 must be accounted for in boxes, not in a sentence three pages later. A diagram that does not add up invites a line-by-line audit of the whole Results chapter.

2. No sample size justification

CONSORT and STROBE both ask how the study size was arrived at. For a trial, report the primary outcome, the expected effect, alpha, power and the allowance for attrition. For a retrospective cohort where the sample was fixed by the available records, say so and report the precision that sample allows. “All eligible patients were included” is acceptable only when followed by what that number can and cannot detect.

3. Effect sizes without confidence intervals

A p-value alone does not tell the examiner how large or how precise the effect is. Report the estimate (mean difference, risk ratio, odds ratio, hazard ratio) with its 95% confidence interval, and for adjusted models report both unadjusted and adjusted estimates with the covariates named. Our guide to regression vs correlation in clinical research covers which estimate fits which question, and the survival analysis guide covers hazard ratios and censoring for time-to-event outcomes.

4. Missing data handling not reported

State how much data were missing for each key variable, why, and what you did about it (complete case analysis, multiple imputation, or another method) with the assumption behind the choice. Committees accept most reasonable approaches; what they do not accept is silence. For trials, also state which analysis population each result uses. The Editverse guide on intention-to-treat vs per-protocol analysis explains how to word this.

5. Outcomes changed without explanation

If the primary outcome in the registered protocol or approved proposal differs from the one reported in the thesis, say so and explain why. Examiners compare the two documents. An unexplained switch reads as selective reporting even when the reason was practical.

6. Search strategy summarised, not shown

PRISMA 2020 asks for the full search strategy for all databases.⁴ A sentence listing database names and keywords does not satisfy it. Put the complete strings, with dates and limits, in an appendix.

DNP Projects: Why SQUIRE 2.0, Not CONSORT

A Doctor of Nursing Practice final project is usually a quality improvement or evidence-based practice implementation project, not a trial. As we explain in DNP vs PhD in nursing, the DNP produces a practice project rather than a research dissertation, so the reporting standard changes with it. Forcing a unit-level practice change into CONSORT creates problems: there is no randomisation to report, no allocation concealment, and the most important information (local context, the theory behind the change, how the intervention was adapted over cycles) has no natural home.

SQUIRE 2.0 was built for exactly that work. It has 18 items and emphasises three things CONSORT does not: the use of formal and informal theory in planning the change, the context in which the work is done, and the study of the intervention itself.⁶

Mapping SQUIRE 2.0 to a DNP project write-up

• Problem description and available knowledge: the clinical gap on your unit, with local baseline data, plus the evidence synthesis that supports the chosen change.
• Rationale: the framework or theory (for example a change model or an implementation framework) and why you expect the intervention to work in this setting.
• Context: unit size, staffing, patient population and organisational factors that could shape the result.
• Intervention and study of the intervention: what changed, who delivered it, how it was adapted across PDSA cycles, and how you checked it was delivered as planned.
• Measures and analysis: process, outcome and balancing measures, with run or control charts for data collected over time.
• Results and interpretation: changes over time, unintended consequences, and what would need to be in place for another unit to sustain the change.

If your DNP project includes a pre-post survey or a small comparison, you can borrow individual items from STROBE for that component, but SQUIRE 2.0 remains the primary checklist. State this choice in the Methods section so the committee does not ask why CONSORT was not used.

How to Build the Checklist Appendix

A completed checklist is only useful if a reader can jump from each item to the place it is reported. Download the current checklist from the guideline’s official source via the EQUATOR Network, then follow these steps:

1. Add a location column. For each item, give the chapter, section heading and page number, for example “Ch 3, 3.6 Sample size, p. 58”.
2. Do not leave items blank. If an item does not apply (blinding in a single-arm study, for example), write “Not applicable” and a short reason.
3. Fill it last. Page numbers move with every edit. Complete the location column after the final formatting pass, then re-check five random items.
4. Name the version. Head the appendix with the guideline name and year (CONSORT 2025, PRISMA 2020) and cite the statement in your reference list.
5. Add extensions where they fit. Cluster, pilot and feasibility trials, and several other designs, have official CONSORT extensions. Use the extension checklist in place of, or alongside, the core one as the extension instructs.
6. Match the reference style. Cite the guideline statements in the style your graduate school requires (AMA, Vancouver, APA, or the university’s own thesis guide).

For observational and trial designs specifically, the Editverse tutorials on STROBE reporting and CONSORT reporting go item by item with worked wording.

Guideline Statements to Cite in a Medical Dissertation

Cite the primary statement for the guideline you used, not a secondary summary. The ten statements below cover the designs in the decision table, and each is the version committees and journals expect in 2026:

• Trials: CONSORT 2025¹ (or CONSORT 2010² if your committee requires it) and SPIRIT 2025¹⁰ for the protocol.
• Observational studies: STROBE.³
• Systematic reviews: PRISMA 2020.⁴
• Diagnostic accuracy: STARD 2015.⁵
• Quality improvement and DNP projects: SQUIRE 2.0.⁶
• Case reports: CARE.⁷
• Qualitative research: COREQ⁸ for interview and focus group studies, or SRQR⁹ for a broader range of qualitative approaches.

Professional Support for Your Medical Dissertation

Reporting gaps are cheapest to fix before a committee reads the chapter. Editverse subject-matter experts in clinical research, biostatistics and nursing review your thesis against the checklist that matches your design, mark every missing or misplaced item, and return the completed checklist appendix with page references. Work is aligned with COPE, ICMJE and GPP3, with institutional and country-specific ethics followed, and formatted to AMA, Vancouver, APA or your university’s own thesis guide.

For a design-specific plan covering proposal, analysis and defense, see the full medical dissertation help service. Non-clinical doctoral candidates can find the broader range of chapter, coaching and committee-response options under dissertation help.

Conclusion

Choosing the right reporting guideline is a five-minute decision; placing its items correctly across a medical dissertation is the work that saves months. Match your design to its checklist using the table above, write the Methods chapter in checklist order, open the Results chapter with a flow diagram that reconciles, report every estimate with its confidence interval, and state how missing data were handled. Then attach the completed checklist with page references. A thesis built this way answers the committee’s reporting questions on paper, which leaves the defense free for the questions that matter: what you found and why it changes practice.

If you want a second pair of eyes on any chapter before it goes to the committee, the Editverse medical dissertation team can review it against your guideline and return a marked checklist.

References

1. Hopewell S, Chan AW, Collins GS, et al. CONSORT 2025 statement: updated guideline for reporting randomised trials. BMJ. 2025;389:e081123. doi:10.1136/bmj-2024-081123
2. Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332. doi:10.1136/bmj.c332
3. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453-1457. doi:10.1016/S0140-6736(07)61602-X
4. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71
5. Bossuyt PM, Reitsma JB, Bruns DE, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ. 2015;351:h5527. doi:10.1136/bmj.h5527
6. Ogrinc G, Davies L, Goodman D, Batalden P, Davidoff F, Stevens D. SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process. BMJ Qual Saf. 2016;25(12):986-992. doi:10.1136/bmjqs-2015-004411
7. Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D; CARE Group. The CARE guidelines: consensus-based clinical case reporting guideline development. BMJ Case Rep. 2013;2013:bcr2013201554. doi:10.1136/bcr-2013-201554
8. Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349-357. doi:10.1093/intqhc/mzm042
9. O’Brien BC, Harris IB, Beckman TJ, Reed DA, Cook DA. Standards for reporting qualitative research: a synthesis of recommendations. Acad Med. 2014;89(9):1245-1251. doi:10.1097/ACM.0000000000000388
10. Chan AW, Boutron I, Hopewell S, et al. SPIRIT 2025 statement: updated guideline for protocols of randomised trials. BMJ. 2025;389:e081477. doi:10.1136/bmj-2024-081477